62N-29139-15038
4 vaccinations
6 coded responses
51 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 923 / CA
- Registered
- 2021-02-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Registered in v-safe
-
2021-02-25
Dose 1 — Pfizer-BioNTech
-
2021-02-25
Survey response — day 0, dose 1MedDRA: Paraesthesia — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Tingling sensation in my arm.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-02-27
- 2021-02-28
-
2021-03-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-11
-
2021-03-18
Dose 2 — Pfizer-BioNTech
-
2021-03-18
Survey response — day 0, dose 2MedDRA: Paraesthesia, Vaccine positive rechallenge — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Tingling in hands and feet (I got it with first shot too)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
- 2021-04-08
-
2021-04-15
Survey response — day 28, dose 2MedDRA: Dyspnoea, Headache — Feeling: GoodFree text: Headaches and difficulty breathing -- probably just allergies. No fever.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-22
- 2021-04-29
- 2021-06-17
- 2021-09-16
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-10-02
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-10-04
Health check-in — day 7, dose 3Feeling: Poor · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend schoolAdult check-in
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
-
2021-12-27
Survey response — 3 months, dose 3MedDRA: Fatigue, Headache, Nasal congestion, Nausea, Oropharyngeal pain, SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I have COVID. Tested positive. Stuffy nose, tired, have to periodically use my inhaler, periodic nausea. Started with sore throat & headache, but those are gone now.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-28
Survey response — 6 months, dose 3MedDRA: Asthma, COVID-19, Memory impairment — Feeling: GoodFree text: Memory issues since I had COVID at the end of December. Asthma has gotten worse since then as well.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-15
Dose 4 — Pfizer-BioNTech
-
2022-04-15
Health check-in — day 0, dose 4Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2022-04-16
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2022-04-17
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-18
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-19
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-04-20
- 2022-04-21
- 2022-04-22
- 2022-04-29
-
2022-05-06
Survey response — day 21, dose 4MedDRA: Diarrhoea, Gastrointestinal disorder, Hypersensitivity, Pre-existing disease, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend schoolFree text: My allergies have been off the chart. I've also been having GI issues, especially loose bowels. I took a rapid COVID test to make sure it was not COVID, it was negative.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-13
- 2022-05-20
- 2022-05-27
- 2022-07-15
- 2022-10-14
- 2023-04-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | |
| 2 | 2021-03-18 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-04-15 | Pfizer-BioNTech | No |
Free text
Release 4 — day 0, dose 1
Systemic reaction (other): Tingling sensation in my arm.
Release 5 — day 0, dose 2
Systemic reaction (other): Tingling in hands and feet (I got it with first shot too)
Release 7 — day 28, dose 2
Symptoms: Headaches and difficulty breathing -- probably just allergies. No fever.
Release 10 — 3 months, dose 3
Symptoms: I have COVID. Tested positive. Stuffy nose, tired, have to periodically use my inhaler, periodic nausea. Started with sore throat & headache, but those are gone now.
Release 11 — 6 months, dose 3
Symptoms: Memory issues since I had COVID at the end of December. Asthma has gotten worse since then as well.
Release 11 — day 21, dose 4
Symptoms: My allergies have been off the chart. I've also been having GI issues, especially loose bowels. I took a rapid COVID test to make sure it was not COVID, it was negative.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Memory impairment | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Vaccine positive rechallenge | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release